CYBIN INC.
Last · NasdaqGM$10.38-0.12 (-1.14%)close · yahoo · 19h ago
Market cap$758.46M73.1M sh
P/E · TTM-2.8fwd -5.8 · eps -4.10 · loss
Beta0.54vs S&P 500
Div yield0.00%annual · TTM
52w range
$3.76$15.15
Volume1.1Msession
Loading chart…
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.95
Est. revenue
0
Press & signals
- GlobeNewswire
Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change
- GlobeNewswire
Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
- GlobeNewswire
Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights
The rest of this company's wire — with summaries and source links — is part of Pro.
See plans